Nuclera raised €10M in a Series C round in Jan 2026. The company is based in Cambridge, UK. Investors in the round: British Business Bank, Elevage Medical Technologies, GK Goh and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.